VanEck Biotech ETF
BBH
126 hedge funds and large institutions have $171M invested in VanEck Biotech ETF in 2021 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 29 increasing their positions, 33 reducing their positions, and 12 closing their positions.
75% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 12
7% more funds holding
Funds holding: 118 → 126 (+8)
5% more capital invested
Capital invested by funds: $163M → $171M (+$8.32M)
2.41% more ownership
Funds ownership: 28.03% → 30.44% (+2.4%)
12% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 33
68% less call options, than puts
Call options by funds: $627K | Put options by funds: $1.95M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$17M |
| 2 |
Morgan Stanley
New York
|
+$3.63M |
| 3 |
Chevy Chase Trust
Bethesda,
Maryland
|
+$2.65M |
| 4 |
CCA
Conservest Capital Advisors
Wynnewood,
Pennsylvania
|
+$1.41M |
| 5 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$1.25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Stifel Financial
St. Louis,
Missouri
|
-$2.49M |
| 2 |
FTUS
Flow Traders U.S.
New York
|
-$2.22M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.8M |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$1.04M |
| 5 |
KWM
Kingsview Wealth Management
Grants Pass,
Oregon
|
-$1M |
BBH Hedge Fund Activity: Q4 2021 in Review
126 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2021, worth a combined $171M — up 5.1% from $163M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new BBH positions and 12 closed out — a net gain of 9 holders — while 29 added to existing stakes and 33 trimmed.
The largest buyer was Bank of America, adding an estimated $17M. The largest seller was Stifel Financial, cutting an estimated $2.49M.
- 126 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2021, up from 118 in Q3 2021.
- Funds reported $171M of VanEck Biotech ETF stock for Q4 2021, up 5.1% quarter-over-quarter.
- 21 funds opened new VanEck Biotech ETF positions in Q4 2021 and 12 closed out, a net change of +9 holders.
- The largest VanEck Biotech ETF buyer in Q4 2021 was Bank of America, an estimated $17M added.
- The largest VanEck Biotech ETF seller in Q4 2021 was Stifel Financial, an estimated $2.49M sold.
Based on aggregated 13F filings for Q4 2021.